Product
HR20013
2 clinical trials
1 indication
Clinical trial
Compared With Fosaprepitant Dimeglumine for Injection and Palonosetron Hydrochloride Injection, to Evaluate the Efficacy and Safety of HR20013 for Injection for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic ChemotherapyStatus: Completed, Estimated PCD: 2023-06-19
Clinical trial
A Phase I Clinical Study of Safety and Pharmacokinetics of Single-dose HR20013 for Injection Combined With Dexamethasone in Patients With Malignant Solid Tumors Receiving Cisplatin-based ChemotherapyStatus: Completed, Estimated PCD: 2023-01-13